Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Application
Item No. 15417

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.
DOWNLOAD THE DATABASEModafinil (Item No. 15417) is an analytical reference standard that is classified as a nootropic. It is a wake-promoting agent that binds competitively and selectively to the dopamine transporter, modulating catecholaminergic signaling by inhibiting its activity (IC50 = 3 μM; Ki = 2 μM).1 With much weaker potency, modafinil can bind the norepinephrine transporter (IC50 < 10 μM) and the serotonin transporter (IC50 > 500 μM).2 Aside from its utility in sleeping disorders, modafinil has also been explored for treating the symptoms of fatigue that are often associated with multiple sclerosis (and other diseases) and as an intervention for cognitive impairments associated with drug addiction.3,4,5 Modafinil is regulated as a Schedule IV compound in the United States. This product is intended for forensic and research applications.
WARNING This product is not for human or veterinary use.
1. Modafinil as a catecholaminergic agent: Empirical evidence and unanswered questions. Front. Neurol. 4, 139 (2013).
2. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33(7), 1477-1502 (2008).
3. Modafinil in the treatment of excessive sleepiness. Drug. Des. Devel. Ther. 2, 71-85 (2008).
4. Cancer-
5. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64, 452-463 (2013).